Medicine Man Technologies, Inc. (SHWZ)
| Previous Close | 0.7600 |
| Open | 0.7945 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.6400 - 0.8375 |
| 52 Week Range | 0.4800 - 1.5500 |
| Volume | |
| Avg. Volume | 67,381 |
| Market Cap | 50.391M |
| Beta (5Y Monthly) | 1.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6600 |
| Earnings Date | May 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.83 |
PR NewswireSchwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024. The Company's results will be reported in a press release prior to the call.
Insider MonkeyMedicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript
Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript March 27, 2024 Medicine Man Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.43 EPS, expectations were $-0.13. Medicine Man Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
CNW GroupSchwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023.
